Stock listing
Cleo Diagnostics Ltd
Selected listing: COV · ASX · AUD · AU
Cleo Diagnostics Ltd (ASX:COV), Health Technology. Latest release Sep 29, 2026: Cleo Files Patents for its Ovarian Cancer Screening Test.
- Ticker
- ASX:COV
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- ASX
- Currency
- AUD
About Cleo Diagnostics Ltd
The company focuses on innovative diagnostic solutions in the healthcare sector. Cleo Diagnostics aims to enhance patient care through advanced technology and research.
Latest news from Cleo Diagnostics Ltd
Cleo Files Patents for its Ovarian Cancer Screening Test
September 29, 2026
CLEO Commences Ovarian Cancer Screening Test Development
September 23, 2026
CLIA Certified Lab selected - Pivotal US Clinical Validation
September 9, 2026
CLEO Receives First Batch of Commercial Test Kits
September 2, 2026
Appendix 4E and 2026 Annual Report
August 20, 2026
Research Cleo Diagnostics Ltd
Cleo Diagnostics Ltd company profile
View the public company page for Cleo Diagnostics Ltd on 6ix.
Cleo Diagnostics Ltd news
Read company news and market updates connected to Cleo Diagnostics Ltd.
Cleo Diagnostics Ltd investor events
Find investor webinars, events, and replay context for Cleo Diagnostics Ltd.